
ãåæããå¿ååãããè¶ ããŠïŒæ¥è§Šè¿œè·¡ã¢ããªã瀺åããæ°ããããŒã¿ã¬ããã³ã¹ã¢ãã«ã®å¿ èŠæ§
ã»ãæ¥è§Šè¿œè·¡ã¢ããªïŒContact Tracing AppïŒ*i ã¯ææçã®æ¡å€§ç¶æ³ã远跡ããæå¹ãªæ¹æ³ã§ããããé©åãªããŒã¿ã¬ããã³ã¹ãå¿
é ã§ããã
ã»ãããŒã¿ã¬ããã³ã¹ã«ãããŠã¯ããã©ã€ãã·ãŒãã¯ãããšããå人ã®äººæš©ãããŒã¿ãã«ããŒã«ãšã£ãŠã®åçæ§åã³å
Œ
±ã®å©çã®å®çŸ ã®3ã€ã®åºæ¬çãªèŠçŽ éã®ãã©ã³ã¹ã«çæãã¹ãã§ããã
ã»ããã³ãããã¯ã®ãããªæ·±å»ãªç€ŸäŒèª²é¡ãžã®ãã©ã³ã¹ã®åããã¢ãããŒããšããŠã瀟äŒçåæã«åºã¥ãå
¬çç®çã®ããŒã¿ã¢ã¯ã»ã¹ïŒAuthorized Public Purpose AccessãAPPAïŒãšããæ çµã¿ãæå±ããã
åäººã®æš©å©ãšç€ŸäŒå
šäœã®ããŒãºãšã®ãã©ã³ã¹
COVID-19ãã³ãããã¯ã«å¯Ÿããæ¥è§Šè¿œè·¡ã¢ããªã®äœ¿çšã¯ããã©ã€ãã·ãŒã人暩ãžã®åœ±é¿ã«é¢ããè°è«ãåŒãèµ·ãããŠãããæ¥è§Šè¿œè·¡ã¢ããªã¯ãŠã€ã«ã¹ã«å¯Ÿãã匷åãªæŠåšã«ãªãå¯èœæ§ãããããè¡æ¿åŽã«ããç£èŠããŒã«ã«ããªããããããã§ããã©ã€ãã·ãŒã®ä¿è·ãããéèŠããããã€ãã®æ°éäŒæ¥ã®åçµã¿ãã§ãŠããããããã®äžã«ã¯ãã°ãŒã°ã«ãšã¢ããã«ãéçºããApple-Google Exposure Notification FrameworkïŒAGFïŒ*1 ããããæ°éãã©ãããã©ãŒã ã®å©çšã¯æ¿åºã®ç£èŠãããŠãŒã¶ãŒãä¿è·ããããæè¡éçºè ãå«ããããŒã¿ãã«ããŒãæ¿åºã®ä»£æ¿çãªç«å Žã«ããªããããã§ãæ°éäŒæ¥ãåéããããŒã¿ãã©ã®ããã«äœ¿çšãããã瀟äŒçã«ç£ç£ããå¿ èŠãçãããAGFã¯åæã«åºã¥ããŠåå è ãç»é²ããããããã§ã¯ææçã®èå»¶ãææ¢ããã«ã¯äžååãªã®ã§ã¯ãªãããšãææãããŠãããäžåœã®ããã«å人æ å ±ãç©æ¥µçã«æŽ»çšããŠããåœã§ã¯ãçžå¯Ÿçã«ãŠã€ã«ã¹æ¡æ£ã®æå¶å¹æãé«ãŸã£ãŠããã*2  åäººã®æš©å©ãšç€ŸäŒå šäœã®ããŒãºãšã®ãã©ã³ã¹ãåãããšã¯ãèŽåœçãªãã³ãããã¯æã®éèŠãªèª²é¡ãšãªã£ãŠããã
æ¥è§Šç¢ºèªã¢ããªã®ïŒã€ã®ã«ããŽãªãŒ
æ¥è§Šè¿œè·¡ã¢ããªã¯ããã®ç®çã«ãã3ã€ã®ã«ããŽãªãŒã«åé¡ãããã*3Â
â ææè
ãéé¢ããæœèšããã®ä»ã®ãšãªã¢ãžã®ã¢ã¯ã»ã¹ãå¶éããããã®ããŒã«
ãŠãŒã¶ãŒã®ææç¶æ³ãææè
åã¯ææã®å¯èœæ§ã®ãã人ãšã®æ¥è§Šã®çšåºŠã«å¿ããŠéäžç®¡çããããã®ãããªã¢ããªã¯äžè¬çã«ãå人ã®è¡åã«å¯ŸããŠè¡æ¿åœå±ãå®ããå¶éã宿œããããã«äœ¿çšãããè¡æ¿åœå±ãåå ã矩åä»ããŠãããäŸãã°ãæœèšãžã®å
¥æ§ãå¶éããäžåœã®ã¢ããªããææè
ãéé¢ããéåœã®ã¢ããªãããã
â¡ å
¬è¡è¡çåœå±ãææè
ãšã®æ¿åæ¥è§Šè
ãç¹å®ã»è¿œè·¡ããããã«äœ¿çšããããã«èšèšãããããŒã«ãã©ã€ãã·ãŒã確ä¿ããããã«æ§ã
ãªèŠå¶åã³æè¡çææ®µãæ¡çšãããŠãããåå ã¯ä»»æã§ãããã®ãå€ããäŸãšããŠãäœçœ®ããŒã¿ïŒã€ã³ããã¢ã€ã¹ã©ã³ããã¬ãŒãïŒåã¯BluetoothïŒã·ã³ã¬ããŒã«ããªãŒã¹ãã©ãªã¢ãè±åœããã©ã³ã¹ïŒã䜿çšããã¢ããªãå«ãŸããã
⢠ææè
ãšã®æ¥è§Šã®å¯èœæ§ã«ã€ããŠéç¥ããããšã«ãããå人ã®è¡åå€å®¹ãä¿é²ããããã«èšèšãããããŒã«æ¿åæ¥è§Šè
ã®å人æ
å ±ã¯åœå±ãšå
±æãããªããäŸãã°ãBluetoothãçšããŠå®å
šã«å¿ååãããããŒã¿ïŒãã€ããã¹ã€ã¹ããšã¹ããã¢ïŒã䜿çšããã¢ããªããäœçœ®æ
å ±ããŒã¿ã®ã¿ïŒã€ã¹ã©ãšã«ïŒã䜿çšããã¢ããªãå«ãŸããã
æ¥è§Šè¿œè·¡ã¢ããªã®ç®çãããŒã¿åãç®¡çæ¹æ³
忣åãåæããŒã¹ã®ã¢ãããŒãã¯ãŠãŒã¶ãŒã®ãã©ã€ãã·ãŒãžã®æžå¿µãæžãããã®ã®ããã³ãããã¯æ¡å€§é²æ¢ã«ã¯å¹æãéå®çãšãªããåœæ°ã®60%以äžã®åå çãæãŸãããšããå ±åããã ã*4 ã·ã³ã¬ããŒã«ã®TraceTogetherã¯ãäžçã§ã屿ã®ãç©æ¥µçã«ããã¢ãŒã·ã§ã³ãå±éããæ¥è§Šè¿œè·¡ã¢ããªã ãã2020幎8æçŸåšã§ãæ®åçã¯37%ã«ãšã©ãŸãããªãŒã¹ãã©ãªã¢ã®COVIDsafeã¯æ®åç22%ãšãªã£ãŠãããã¢ããªã®äœ¿çšãä»»æã§ãããšãåå çãäŒžã³æ©ãå¯èœæ§ãé«ãããã©ã€ãã·ãŒä¿è·ã®ããã«å©çšè
ã®åæã«é床ã«äŸåããã¢ãããŒãã§ã¯ãCOVID-19ã®ãããªãã³ãããã¯ã«ååã«å¯ŸåŠã§ããªããšäž»åŒµããå°éå®¶ããã ã*5 äžæ¹ã§ãè¡æ¿åœå±ã®ããŒã¿éçŽã«ããã¢ãããŒãããç£èŠç€ŸäŒãã«ã€ãªããã®ã§ã¯ãªãããšããæžå¿µãé«ãŸã£ãŠãã ã*6
ãåæãããŸãã¯å¿ååãããè¶
ããŠ
ãããŸã§ãæ¥è§Šè è¿œè·¡ã®ææ³ãšããŠã¯ãåæãšå¿ååã®ãããããããã¯ãã®äž¡æ¹ã®çµã¿åãããšããŠè°è«ãããŠãããã€ãŸããæ¥è§Šè¿œè·¡ã¢ããªã§ã¯ãåäººã®æç€ºçãªåæã確ä¿ããããå人ãç¹å®ã§ããæ å ±ãåéããå Žåã«ã¯ãã®ããŒã¿ãåé€ããå¿ èŠãããããããããããæ¬åœã«å¯äžã®éžæè¢ãªã®ã ããã?ãæã ã¯ãä»ã®è§£æ±ºçãããåŸããšèããŠãããæè¿ã®äžççµæžãã©ãŒã©ã ã®ãã¯ã€ãããŒããŒã§ç€ºããã瀟äŒçåæã«åºã¥ãå ¬çç®çã®ããŒã¿ã¢ã¯ã»ã¹ïŒAuthorized Public Purpose AccessãAPPAïŒã®æ çµã¿ã¯ãå¿ ãããæç€ºçãªå人ã®åæã«ããããåæããªãå Žåã®ããŒã¿ã®å¿ååã«ãäŸåããŠããªããããã¯ãåäººã®æš©å©ãããŒã¿ãã«ããŒã«ãšã£ãŠã®åçæ§ãåã³å ¬å ±ã®å©ç ãšãã3ã€ã®éèŠãªèŠçŽ ã«æ³šç®ããèŠçŽ éã®ãã©ã³ã¹ãåãããšãç®æããŠããã
Authorized Public Purpose AccessïŒAPPAïŒã®æ çµã¿
APPAã¯ã瀟äŒçåæããªãããç¹å®ã®å
¬çãªç®çã®ããã§ããã°ãå¿
ãããæç€ºçãªå人åæã«ããããšãªãå人ã®äººæš©ãå¥ã®åœ¢ã§ä¿éããããŒã¿ãžã®ã¢ã¯ã»ã¹ãèš±å¯ããããšã§ç®çãšãã䟡å€ãå®çŸããã¢ãã«ã§ãããããªãã¡ãã¬ããã³ã¹ã«é¢ããéèŠãªè³ªåããç¹å®ã®ããŒã¿ãææããŠããããããã©ã®ãããªç¶æ³ã§èª°ã«ããŒã¿ã¢ã¯ã»ã¹ãèš±å¯ãã¹ãã?ãã«ã·ããããŠããã
COVID-19察çã«ãããŠããŒã¿ïŒäººã
ã®å¥åº·ãåããªã©ã«é¢ããæ
å ±ïŒã«ã¢ã¯ã»ã¹ãããç®çãã¯ããŠã€ã«ã¹ã®æ¡æ£ãæå¶ããåœãæãããšã§ãããããå
·äœçãªãå
¬è¡è¡çäžã®ç®æšåã³ã¢ãããŒãã¯åœã«ãã£ãŠç°ãªããã APPAãšããŠèš±å®¹ãããããã«ã¯ãããé©åãªå
·äœæ§ãæã£ããç®çããæ±ããããããŸããAPPAãšããŠã¯ãç®çãæ£çµ±ã« ãæ¿èªã ãããŠããããšãã€ãŸã瀟äŒçã³ã³ã»ã³ãµã¹ã®ç£ç©ã§ãããäžè¬ã®äººã
ããä¿¡é Œãããçµç¹ã«ãã£ãŠç£èŠãããŠããããšãåæãšããŠããããããã®æ¡ä»¶ãæºããããŠåããŠã¬ããã³ã¹ãé©åãšèããããã
APPAãCOVID-19ã«ã©ã®ããã«åãçµãã
APPAã«åºã¥ãããŒã¿ã¬ããã³ã¹ã¯ããã®æ çµã¿ãçšããããŒã«ã«ããã©ã®ããã«ããŒã¿ãã¢ã¯ã»ã¹ãããã¹ãããææ¡ããŠããããã®ã¹ãããã¯ä»¥äžã®ãšããã§ããã
ã»ã å人æ
å ±ãå«ããåŠã確èªãããç¹ã«ãéåžžã¯ãã©ã€ãã·ãŒå¶éã®å¯Ÿè±¡ãšãªãæ©å¯æ§ã®é«ãå人æ
å ±ãå«ãŸããŠãããã
ã»ãåæã®æç¡ã確èªãããããŒã¿ãå人çãªãã®ã§ããå ŽåãããŒã¿äž»äœã¯ãã®äœ¿çšã«åæããŠããããããã¯é©åãªåæã§ãããã
ã»ãAPPAãã¯ã€ããªã¹ãã確èªãããç¹ã«ã¢ã¯ã»ã¹ãæ¿èªãããŠããçš®é¡ã®ããŒã¿ïŒäŸãã°ç¹å¥æ³ã«ããïŒã¯ãæå®ãããç®çã®ããã«äœ¿çšãããŠãããã
ã»ã 第äžè
ã«ããã¬ãã¥ãŒã確ä¿ãããç¬ç«å«çå§å¡äŒåã¯ãã®ä»ã®ç£ç£æ©é¢ãAPPAå€æèŠæºã®éµå®ãæ€èšŒããã
ãã®æ çµã¿ã«åºã¥ããšãå人æ å ±ãå«ãŸãªã圢ã§ã®æ¥è§Šè¿œè·¡ã¢ããªã®äœ¿çšã¯åé¡ãªããããããå人ã®è¡åã远跡ããã¢ããªã¯ãå€ããå人æ å ±ãå¿ èŠãšãããããã§ãããŒã¿äž»äœã®åæãæ±ããããïŒã¹ããã2ïŒãAGFãå«ãå€ãã®æ¥è§Šè¿œè·¡ã¢ããªã¯ããã®çµæèš±å®¹ããããAPPAã®ç¹åŸŽçãªæ çµã¿ã¯ã¹ããã3以éãšãªãããããŸã§ã®æµãã¯ãå人æ å ±ã管çããããã®æ¢åã®åæã«åºã¥ãã¢ãããŒããšå€§ããªéãã¯ãªããããããåæã«åºã¥ã察çã§ã¯çŸæ£ã®æ¡å€§ãæå¶ããã«ã¯äžååã§ãããAPPAã®äžã§ã¯ãç®çãåºãåæããã䜿çšãããããŒã¿ã®çš®é¡ãæç¢ºã«å®çŸ©ãããŠããéããCOVID-19ã远跡ããããã«å¿ èŠãªå人ããŒã¿ãžã®ã¢ã¯ã»ã¹ãå¯èœãšãªãAPPA ããã¯ã€ããªã¹ããã¯ç¹å¥æ³ãæ¡äŸãå¶å®ããŠäœæããã®ãè¯ããããããªããïŒããã¯åºæ¬çã«ãå ¬è¡è¡çç·æ¥äºæ ã«å¯ŸåŠããããã«2015幎ã«ãã©ã€ãã·ãŒæ³ãæ¹æ£ããéåœãåã£ãã¢ãããŒãã§ããïŒ
APPAã«ããã¬ããã³ã¹ã®æ çµã¿
APPAã¢ãããŒãã«ã¯ç¬¬äžè
æ©é¢ã«ããç£æ»ãå«ãŸãããããŒã¿ã³ã¢ã³ãºã®ãããªæ°ããããŒã¿ç®¡çãã©ãããã©ãŒã ãå©çšãã第äžè
ç£æ»ãããããšã«ãã£ãŠåäººã®æš©å©ãä¿è·ã§ããå¯èœæ§ããããéèŠãªæ®ããã課é¡ã¯ã第äžè
æ©é¢ãã©ãã«ã©ã®ããã«èšç«ããèªèšŒãããããããŠåœŒããç£æ»ããããã«ã©ã®ããã«ããŒã¿ã¢ã¯ã»ã¹æš©ãä»äžãã¹ãããå
·äœçã«æ±ºå®ããããšã§ããã
çŸæç¹ã§ã¯ãCOVID-19ã®ãã³ãããã¯ãçµæ¯ãããŸã§ã®éçã¯äŸç¶ãšããŠäžéæã§ãããå»ã
ãšå€åããç¶æ³ã«ãããŠãå¹
åºãã¹ããŒã¯ãã«ããŒãšã®ããå€ãã®è°è«ãéããããšã«ãããAPPAãçŸå®ã®ãã®ãšããããšãã§ããããã®å€åã¯å®¹æã§ã¯ãªãããã¹ãŠã®å©çã®ããã«åé¡ã解決ããããã®æè¡ã®äœ¿çšãå
å«ããæ°ããªç€ŸäŒçåæãå¿
èŠãšããã§ãããããã®æ°ããèãæ¹ã¯ããã©ã€ãã·ãŒããã®ä»ã®åé¡ã«é¢ããæžå¿µãšã䟡å€ãåµåºãçæŽ»ãæ¹åããå¯èœæ§ãšã®ãã©ã³ã¹ãåããã®ã§ãããããã§ãããã³ãããã¯ã¯å€§ããªå€åãããã«èµ·ãããåºç¯ãªååãå¯èœã§ããããšã瀺ããŠãããAPPAã¯COVID-19ãåŸæããããã®æåœåªåãæ¯æŽããã ãã§ãªããæ°ããæè¡çãã€ã³ãã»ãããæŽ»æ§åããããšãã§ããããã®ãããªå€é©ã¯ãåäººã®æš©å©ãããŒã¿ãã«ããŒã®åçæ§åã³å
Œ
±ã®å©çããã©ã³ã¹ãããããŒã¿ã¬ããã³ã¹ã®æ°æä»£ãå°ãå¯èœæ§ããããšæã
ã¯æåŸ
ããŠããã
äžççµæžãã©ãŒã©ã ç¬¬åæ¬¡ç£æ¥é©åœæ¥æ¬ã»ã³ã¿ãŒ
ãã«ã¹ã±ã¢ã»ããŒã¿æ¿çãããžã§ã¯ãé·ãè€ç°åä»
ãã«ã¹ã±ã¢ã»ããŒã¿æ¿çãããžã§ã¯ããã§ããŒã岡æ¬é
å
çè 玹ä»
*i æ¥æ¬ã§ã¯ãè¿œè·¡ã®æ©èœããªãããæ¥è§Šç¢ºèªã¢ããªãšããåç§°ãšãªã£ãŠããããŸããApple/Googleã¯æé²éç¥ïŒExposure NotificationïŒãšããåŒã³æ¹ãããŠãããÂ
*1 Â https://phii.org/sites/default/files/DT4CT%20White%20Paper_6.30.20-v2.pdf
*2 Â https://covid19.who.int/
*3 Â https://cio.go.jp/node/2605?fbclid=IwAR0yT_hpstfcS843zUiMCuFc9bKbzjTui5fxQsJJwE6XULqUzjntyBgmdIo Document No.4 from the 1st Expert Meeting in May, 2020
*4 Â https://www.research.ox.ac.uk/Article/2020-04-16-digital-contact-tracing-can-slow-or-even-stop-coronavirus-transmission-and-ease-us-out-of-lockdown
*5 Â https://www.technologyreview.com/2020/03/24/950361/coronavirus-is-forcing-a-trade-off-between-privacy-and-public-health/
*6 Â https://www.ft.com/content/005ab1a8-1691-4e7b-8e10-0d3d2614a276
https://www.mq.edu.au/__data/assets/pdf_file/0012/977493/Joint-Statement-on-Contact-Tracing.pdf




